StockNews.AI
ABT
Benzinga
10 days

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings

1. Abbott Laboratories reported Q1 adjusted EPS of $1.09, beating expectations. 2. Q1 sales reached $10.36 billion, up 7.2% year-over-year. 3. Guidance for Q2 adjusted EPS is $1.23-$1.27, in line with consensus.

5 mins saved
Full Article

FAQ

Why Bullish?

ABT’s strong Q1 results suggest growth potential, similar to past performance spikes.

How important is it?

Strong earnings growth can drive immediate interest and investment decisions.

Why Short Term?

Earnings reports typically influence stocks immediately; confidence may enhance investor interest.

Related Companies

Related News